Clinical Trials Procurement Intelligence: Clinical Trials category is expected to have pricing growth outlook of 5.8% From 2023 To 2030
Clinical Trials Procurement Intelligence
This clinical trials category is anticipated to grow at a CAGR of 5.8% from 2023 to 2030. North America is the leading region in this category, accounting for over 50.5% of the market share in 2022. This is expected to continue in the forecast period as well, due to several factors, including increased R&D investments and the adoption of new...
0 Comments
0 Shares
472 Views
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
urdu